Safety Testing Sample Clauses

Safety Testing. (a) OBI shall conduct toxicology, stability and other safety tests (“Safety Testing”) on all Product(s) prior to making such Product(s) available for purchase by VCD.
AutoNDA by SimpleDocs
Safety Testing. The goal of this task is to demonstrate the high level of safety with Li-ion cells using LiGas Electrolytes. The safety testing will closely follow UL1642 guidelines. Each test will have cell data recorded such as voltage, temperature. In addition, a small module with at least 5 cells will be tested via over charge or thermal ramp to demonstrate no cell-to-cell thermal propagation. To conduct the tests cells will be built based off the learnings from previous tasks. Once the experiments are completed a report of the results and lessons learned will be documented in a Verification Report of Safety Testing. The Recipient shall: • Conduct safety testing on thermal ramp, crush, over charge, external short circuit, and spark ignition. • Conduct a testing on a small module with at least 5 Li-ion cells using LiGas Electrolytes via over charge or thermal ramp to demonstrate no cell-to-cell thermal propagation. • Create a Verification Report of Safety Testing that includes but is not limited to: o A high-level summary of the process for safety testing.
Safety Testing. Contractor will test equipment as outlined in federal, state, and local safety codes toensure inspections will be passed. The testing includes but is not limited to the following: ▪ Perform governor, safety, and load tests ▪ Perform pressure and equipment test ▪ Correct deficiencies and meet compliance requirementsAdhere to new published safety rules/standards Contractor will perform all required safety tests as indicated by the State of Montana Elevator Safety Program. Upon completions ofthe required tests, Contractor will promptly submit the test results to the State of Montana Elevator Program.
Safety Testing. Test equipment in accordance with those annual periodic testing requirements as outlined in the American National Safety Code for Elevators and Escalators, ANSI A 17.1, Which are in effect at the time this agreement is executed. In the event that the state, city or local governing authority in which the equipment is located has adopted different requirements, test equipment in accordance with those annual periodic testing requirements in effect at the time this agreement is executed. The cost of the annual testing is included as part of this quote and service and included in the quarterly bid.
Safety Testing. Accordingly with Option1 of ICH guideline S2 (R1) on genotoxicity testing and data interpretation for pharmaceuticals intended for human use, the ERN’s Commercially Reasonable Efforts for performing the qualification of degradation product profile of the Product will be: About genotoxicity,
Safety Testing. The goal of this task is to demonstrate a safety level of the battery prototypes superior to those of a commercial Li-ion battery with a similar energy level. The safety tests will be conducted in accordance with applicable current test standards for batteries. The Recipient shall: • Prepare a Safety Test Plan that describes test objectives, procedures, test schedules, conditions, facilities, and equipment used to test. • Procure required number of commercial Li-ion cells with energy similar to 5 Ah prototypes for the tests according to the Safety Test Plan. • Assemble required number of 5 Ah prototypes according to the Safety Test Plan. • Deliver the cells to the safety test facility. • Conduct safety tests according to the Safety Test Plan. • Prepare a Safety Report that describes the results of the safety tests, including a discussion on issues encountered and steps taken to address them. Products: • Safety Test Plan • Safety Report (draft and final)

Related to Safety Testing

  • Testing Landlord shall have the right to conduct annual tests of the Premises to determine whether any contamination of the Premises or the Project has occurred as a result of Tenant’s use. Tenant shall be required to pay the cost of such annual test of the Premises; provided, however, that if Tenant conducts its own tests of the Premises using third party contractors and test procedures acceptable to Landlord which tests are certified to Landlord, Landlord shall accept such tests in lieu of the annual tests to be paid for by Tenant. In addition, at any time, and from time to time, prior to the expiration or earlier termination of the Term, Landlord shall have the right to conduct appropriate tests of the Premises and the Project to determine if contamination has occurred as a result of Tenant’s use of the Premises. In connection with such testing, upon the request of Landlord, Tenant shall deliver to Landlord or its consultant such non-proprietary information concerning the use of Hazardous Materials in or about the Premises by Tenant or any Tenant Party. If contamination has occurred for which Tenant is liable under this Section 30, Tenant shall pay all costs to conduct such tests. If no such contamination is found, Landlord shall pay the costs of such tests (which shall not constitute an Operating Expense). Landlord shall provide Tenant with a copy of all third party, non-confidential reports and tests of the Premises made by or on behalf of Landlord during the Term without representation or warranty and subject to a confidentiality agreement. Tenant shall, at its sole cost and expense, promptly and satisfactorily remediate any environmental conditions identified by such testing in accordance with all Environmental Requirements. Landlord’s receipt of or satisfaction with any environmental assessment in no way waives any rights which Landlord may have against Tenant.

  • Acceptance Testing At the time of installation of a LIS trunk group, and at no additional charge, acceptance tests will be performed to ensure that the service is operational and meets the applicable technical parameters.

  • Sampling The Licensee agrees that the Composition is purchased as a “Work Made for Hire” whereby the clearing of any sampled materials is the responsibility of Licensee.

  • Tests 7.7.1 If the Contract Documents, laws, ordinances, rules, regulations or orders of any public authority having jurisdiction require any portion of the Work to be inspected, tested or approved, the Contractor shall give the Architect timely notice of its readiness so the Architect may observe such inspection, testing or approval. The Contractor shall bear all costs of such inspections, tests or approvals conducted by public authorities.

  • Tests and Preclinical and Clinical Trials The preclinical studies and clinical trials conducted by or, to the Company’s knowledge, on behalf of the Company or any of its subsidiaries, that are described in the Registration Statement and the Prospectus, as applicable, and are intended to be or have been submitted to FDA or other comparable governmental entities, were and, if still ongoing, are being conducted in all material respects in accordance with experimental protocols, applicable Authorizations, and Applicable Laws, including, without limitation, the Federal Food, Drug and Cosmetic Act and the rules and regulations promulgated thereunder and, for studies submitted to regulatory authorities for approval, in all material respects, current Good Clinical Practices and Good Laboratory Practices and any applicable rules and regulations of the jurisdiction in which such trials and studies are being conducted; the descriptions of the results of such studies and trials contained in the Registration Statement and the Prospectus are, to the Company’s knowledge, accurate and complete and fairly present the data derived from such studies and trials in all material respects; except to the extent disclosed in the Registration Statement and the Prospectus, the Company and each of its subsidiaries, is not aware of any studies or trials, the results of which the Company believes materially call into question the study or trial results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described and the clinical stage of development; and, except to the extent disclosed in the Registration Statement or the Prospectus, the Company or any of its subsidiaries have not received any written notices or correspondence from the FDA or any governmental entity requiring the termination or suspension of any preclinical studies or clinical trials conducted by or on behalf of the Company or any of its subsidiaries, other than ordinary course communications with respect to modifications in connection with the design and implementation of such trials, copies of which communications have been made available to you.

Time is Money Join Law Insider Premium to draft better contracts faster.